Rajiv Panwar
About Rajiv Panwar
Rajiv Panwar is the VP of CMC and Clinical Supply Chain, with a strong background in pharmaceutical sciences and significant contributions to cancer research.
Rajiv Panwar - VP, CMC and Clinical Supply Chain
Rajiv Panwar currently holds the position of Vice President of Chemistry, Manufacturing, and Controls (CMC) and Clinical Supply Chain. In this role, he oversees the supply chain management and clinical trial logistics for pharmaceutical products. He is also responsible for ensuring that manufacturing processes comply with regulatory standards and meet the highest quality assurance requirements.
Rajiv Panwar's Education in Pharmaceutical Sciences
Rajiv Panwar earned a Bachelor of Science in Pharmaceutical Sciences from MD University in India. He further advanced his expertise by earning both a Master of Science and a PhD in Interdisciplinary Pharmaceutical Sciences from Northeastern University in Boston. His education has provided him with a solid foundation in pharmaceutical technologies and methodologies.
Rajiv Panwar's Career Background
Rajiv Panwar started his career at Akrivis Technologies, where he led the development of technologies targeting small size tumor lesions and cancer stem cells. His innovative work at Akrivis resulted in multiple NIH/NCI awards. He has also held roles at Magenta Therapeutics and Eleven Biotherapeutics, further honing his skills in drug development and supply chain management before taking on his current VP role.
Rajiv Panwar's Early Achievements at Akrivis Technologies
Rajiv Panwar made significant contributions at Akrivis Technologies by leading the development of new technologies aimed at targeting small size tumor lesions and cancer stem cells. His work garnered multiple awards from the National Institutes of Health (NIH) and the National Cancer Institute (NCI), solidifying his reputation in the field of pharmaceutical innovations and research.